Development of a new analog of SGK1 inhibitor and its evaluation as a therapeutic molecule of colorectal cancer

Colorectal cancer (CRC) is one of the most leading causes of cancer-related death worldwide. The serum and glucocorticoid inducible kinase SGK1 is highly expressed and involved in several tumors. GSK650394, a SGK1 inhibitor, has been proved to be effective in impeding tumor growth in vitro. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Xuchun, Lan, Chunling, Zhou, Jinzhe, Fu, Wencheng, Long, Xuesha, An, Yu, Jiao, Guanming, Wang, Kejin, Li, Yongqin, Xu, Jiahong, Huang, Qi, Xu, Bin, Xiao, Junjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560143/
https://www.ncbi.nlm.nih.gov/pubmed/28819428
http://dx.doi.org/10.7150/jca.19566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560143/
https://www.ncbi.nlm.nih.gov/pubmed/28819428
http://dx.doi.org/10.7150/jca.19566

Ejemplares similares